Activity Summary:
The management of Psoriatic Arthritis (PsA) remains challenging, owing to variable clinical presentations and ever-changing therapeutic options. Optimizing outcomes for PsA is dependent upon the early identifying patients, developing a personalized treatment strategy, and cohesively collaborating with a multidisciplinary team to address issues related to the challenges of diagnosis and access to appropriate therapy. Furthermore, research in PsA has evolved in recent years to reflect changes in the current disease landscape, study population, new management strategies, advanced recommendations on assessing patients’ overall disease activity and responses to treatment, healthcare providers’ and patients’ treatment expectations, and regulatory requirements. Understanding these can help guide clinical decision-making and improve outcomes for patients with PsA.

Talking PsA is an accredited AMA/ANCC/ACPE activity that highlights the very latest clinical data and is designed to optimize treatment strategies in PsA through a series of four patient case studies. The content and clinical cases were developed and presented by leading Rheumatology and Dermatology experts in PsA.

Activity Summary:
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Pulmonary arterial hypertension (PAH) is a progressive and fatal lung disease of multifactorial etiology. Currently, therapies for treating pulmonary hypertension have been used alone and in combination to demonstrate improvements in quality of life and hemodynamic parameters as well as in slowing disease progression; however, beneficial effects on survival are limited. None offer a cure against PAH nor directly address the underlying cellular proliferation that leads to increased pulmonary arterial pressure, and the median survival rate remains at 61% at five years after diagnosis. Extensive research efforts have led to the emergence of innovative therapeutic approaches in PAH. This on-demand webcast focuses on several important aspects of PAH management, including a discussion of the challenges diagnosing and treating patients, clinical trial data on emerging therapeutics for the management of PAH, and a review of strategies to optimize outcomes for patients with PAH.

Activity Summary:
The expansion of PrEP provision could help to stem the number of new HIV infections globally. Studies are underway to optimize their tolerability with novel regimens and methods of delivery in the hope that persons with diverse patterns of sexual risk and personal preferences will find chemoprophylaxis to be acceptable and beneficial. However, in addition to antiretroviral regimen tolerability and efficacy, there are clearly social and behavioral factors that impact adherence to medications and associated clinical monitoring, which remain suboptimal in some populations; developing interventions to support adherence to chemoprophylaxis will be essential.

In this episode of Conversations in HIV, the faculty engages in a thought-provoking discussion identifying strategies to facilitate successful and sustainable implementation of PrEP for specific patients to include a MSM and IDU at Risk for HIV, Cisgender Woman Without HIV and MSM with Multiple Comorbidities.

Activity Summary:
This accredited continuing education webcast archive was presented by HIV specialists who practice in the southern United States. Geographically appropriate topics and practical strategies for cisgender women such as ending the HIV epidemic, HIV/STI screening, and HIV prevention/treatment considerations are discussed.

Activity Summary:
The Talking Multiple Myeloma webcast archive will highlight recent advances in the initial management of multiple myeloma (MM).

Through patient cases and scenarios, the expert faculty presenters will discuss practice-changing updates in the initial management of MM, strategies to improve patient outcomes and prevent/manage adverse events as well as guide the integration of new evidence into clinical treatment paradigms.

Activity Summary:
With the recent approval of atezolizumab and osimertinib, and several ongoing trials, it has become clear that immunotherapy and targeted approaches are gaining ground in the adjuvant and neoadjuvant setting of early-stage non-small cell lung cancer (NSCLC). Considering the continual updates from clinical trials in this space, it is pivotal that healthcare professionals are familiar with the practical considerations to safely integrate this recent progress.

This activity will highlight the practice-changing updates in adjuvant and neoadjuvant approaches in early-stage NSCLC, to enable safe and effective implementation into clinical practice through expert-guided discussions with Drs. Julie Brahmer, Jamie Chaft and Stephen Liu.

Activity Summary:
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Recent progress in pulmonary arterial hypertension (PAH) is based on new strategies for combination therapy and the escalation of treatments to improve the significant morbidity and mortality associated with this disease. This on-demand presentation is a case-based discussion on the importance of a proper workup to reach the correct diagnosis and monitoring patients to determine when and how to optimally alter their PAH therapy.

Activity Summary:
Combining tyrosine kinase inhibitor and immunotherapy agents has shown considerable promise in Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL). Although this approach can provide a chemotherapy-free and transplantation-sparing alternative, it is imperative that healthcare professionals are familiar with the practical considerations to safely integrate this recent progress.

This certified AMA activity will highlight the practice-changing updates in the frontline treatment of Ph+ ALL and provide guidance on effective implementation of new evidence through expert-guided discussions and interactive case scenarios.

Activity Summary:
Immune thrombocytopenic purpura (ITP) is a hematological autoimmune disorder characterized by low platelet count in the blood, which may lead to bruising and bleeding. For many years, immune-modulating therapies, such as corticosteroids, immunoglobulins (IVIG and anti-RhD), and rituximab, were the mainstays of treatment in ITP. Since 2008, the approval of thrombopoietin-receptor agonists (TPO-RAs) including a second-generation oral TPO-RA and a spleen tyrosine kinase (Syk) inhibitor, revolutionized the treatment landscape of ITP by opening new and highly effective avenues of treatment. This landscape will be further transformed with a sizable clinical pipeline including inhibitors of CD20, CD40, neonatal Fc receptor (FcRn), bruton’s tyrosine kinase (BTK), and Syk signaling.

This slide kit is designed to keep busy clinicians abreast of the emerging evidence for available treatments and the novel therapy pipeline, to optimize the treatment and care for patients with ITP.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Currently the South is the epicenter of the HIV epidemic in the United States. It experiences the greatest burden of HIV and deaths, and improvement is needed in providing HIV prevention services and care. Closing these gaps is essential to the health of people in the region and meeting the national goal of ending the HIV epidemic.

These accredited continuing education webcasts will be presented by HIV specialists who practice in the Southern United States. Geographically appropriate topics and practical strategies such as Adolescence, Sexual and Gender Minorities and Cisgender Women populations will be discussed.

Activity Summary:

This accredited continuing education webcast archive was presented by HIV specialists who practice in the southern United States. Geographically appropriate topics and practical strategies within sexual and gender minorities such as ending the HIV epidemic, HIV/STI screening, and HIV prevention/treatment considerations are discussed.

Activity Summary:
This AMA/ANCC/ACPE activity features a recorded discussion among three leading pulmonary hypertension (PH) experts and is designed to keep healthcare professionals on top of the most recent clinical findings.

New information is constantly being learned about the management of patients with PH. Pulmonary Hypertension Due to Interstitial Lung Disease (PH-ILD) represents a complex condition which now has a recently approved inhaled therapy to improve exercise ability. Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but treatable complication of PE, which is often indistinguishable from pulmonary arterial hypertension (PAH). All patients with PH benefit from intensive, continuous clinical monitoring either in person or remotely to guide escalation of treatments. PH remains a disease with poor outcomes, necessitating early diagnosis and appropriate intervention. Improvements in survival and care depends on improving clinician awareness of the latest research and perspectives. This activity brings cutting-edge research to busy clinicians enabling them to readily keep abreast of emerging published research as it relates to the management of PH.

Activity Summary:
Conversations in PAH are accredited, on-demand video presentations that feature leading experts discussing hot topics, recent clinical updates, conference updates and treatment options for managing patients with PH. This activity is designed to keep healthcare professionals on top of the most recent clinical findings. Two video series will be launched in 2022.

Activity Summary:
Advances in HIV research often unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest advances in the treatment and prevention of HIV and related comorbidities with a series of ‘what you need to know’ videos from data presented during the 24th International AIDS Conference.

Activity Summary:
New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from April through June of 2022 will discuss the most clinically relevant information regarding HIV Epidemiology and Prevention, Treatment-Experienced Patients and Pregnancy and Non-ART.

Activity Summary:
Recognizing and discussing significant developments and strategies in ART places healthcare professionals at the forefront of HIV care. In addition, new frontiers for HIV therapy continue to be explored, as underscored by the clinical development of long-acting regimens and first-in-class antiretroviral agents.

This activity will provide a discussion-based format, from an innovative HIV clinic, to discuss the advantages and limitations of current ART, the implementation of new ART classes/formulations, and the impact new drugs/formulations have on ART management.

Activity Summary:
Learning from Success highlights key, successful strategies to incorporating new ART treatment and prevention options successfully into practice. This discussion based, video presentation will take you directly inside innovative and proven clinics that are involved in providing cutting-edge care to patients with HIV. The first video will focus on an innovative treatment clinic to discuss HIV treatment strategies; the second will focus on a clinic that spearheads HIV prevention services. Several care providers at each clinic will be interviewed and discuss scenarios on how to successfully incorporate new strategies and options for the prevention and treatment of HIV.

Please click on your preferred topic to view each series of episodes. Each activity’s duration will be approximately one hour total. Each one-hour video will be broken into shorter chapters for easier viewing. Video and audio-only files as well as PowerPoint slides are available for downloading.

Activity Summary:

This program will use a case-based format that incorporates the patient voice to discuss patient treatment concerns, translatability of recent study results to clinical practice, and management strategies to improve patient outcomes.

As our understanding of HIV and HIV therapy progress, so do our management approaches. Learning about concerns/barriers that patients with HIV face can lead to improved individualized outcomes as well as place the healthcare professional at the forefront of HIV care.

Activity Summary:
This accredited continuing education webcast archive was presented by HIV specialists who practice in the Southern United States. Geographically appropriate topics and practical strategies within the adolescent population such as ending the HIV epidemic, assessing sexual risk behaviors, and HIV prevention/treatment considerations are discussed.

Activity Summary:
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Through patient cases, Sonja Bartolome, MD, FCCP and Dunbar Ivy, MD provide learners with the opportunity to enhance clinical decision-making skills about the diagnosis and management of PAH. This on-demand presentation will take the learner through a complete virtual patient tour starting at the time of symptoms of PAH through diagnosis, evaluation, and how the disorder is managed. In Case 1, Dr. Bartolome presents how to manage the complications and precautions in a patient through pregnancy, labor and delivery, and the immediate postpartum period. In Case 2, Dr. Ivy presents the common features of pediatric PAH with adult disease including the challenges that require unique approaches.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Over the past two decades, research has vastly improved the understanding of the pathophysiology, diagnosis and treatment of PAH. While no therapies have been approved to target new mechanisms of action in more than 5 years, several phase 2 and phase 3 clinical trials of novel targets have begun. Improvements in the care of PAH patients depends on improving clinician awareness of the latest research into new diagnostic techniques, medications, and monitoring. This slide kit brings cutting-edge research to busy clinicians enabling them to readily keep abreast of the published research.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Lightning Reports are accredited, on-demand video presentations that feature experts discussing recent clinical updates, hot topics and treatment options. These activities are designed to keep healthcare professionals on top of the most recent clinical findings.

This series of certified AMA/ANCC/ACPE enduring videos will spotlight the latest advances in the management of bladder cancer through a series of ‘what you need to know’ videos featuring a leading expert reporting from the 2022 ASCO Annual Meeting.

Activity Summary:
Lightning Reports are accredited, on-demand video presentations that feature experts discussing recent clinical updates, hot topics and treatment options. These activities are designed to keep healthcare professionals on top of the most recent clinical findings.

This series of certified AMA/ANCC/ACPE enduring videos will spotlight the latest advances in the management of lung cancer treated with targeted therapy through a series of ‘what you need to know’ videos featuring a leading expert reporting from the 2022 ASCO Annual Meeting.

Activity Summary:
Lightning Reports are accredited, on-demand video presentations that feature experts discussing recent clinical updates, hot topics and treatment options. These activities are designed to keep healthcare professionals on top of the most recent clinical findings.

This series of video highlights will cover bladder cancer and targeted therapy in lung cancer based on data presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

Activity Summary:
The Clinical Viewpoints Hereditary Angioedema lecture series includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slides developed and approved by key expert physicians and further reviewed and approved by the Planning Committee.

Hereditary angioedema (HAE) is a potentially life-threatening genetic condition that presents many unique challenges. The diagnosis of HAE is based on suggestive clinical history and physical findings. In addition, optimal management relies on a patient-centered and shared decision-making approach despite the recent significant advances in treatment options. This activity uses a case-based approach to discuss new and existing diagnostic approaches, options for on-demand medications, and individualized strategies for long-term management.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
The Clinical Viewpoints Hereditary Angioedema lecture library includes a curriculum that highlights the very latest clinical data utilizing a library of PowerPoint slide presentations developed and approved by key expert faculty. The slides will be continuously evaluated and updated for current relevance.

Activity Summary:
Despite dramatic advances in the development of treatments for pulmonary arterial hypertension (PAH), it remains a chronic life-threatening illness for which there is no cure. Advances in knowledge within the field are eagerly anticipated.

These educational Clinical Clips will spotlight important research into the basic science, diagnosis, treatment, and medical management of patients with PAH based on data presented at the American Thoracic Society (ATS) International Conference in San Francisco, California, May 13-18, 2022 through a series of two ‘What You Need to Know in 5-minutes’ videos.

Activity Summary:
Simply Speaking PAH includes a curriculum that highlights the very latest clinical data in pulmonary arterial hypertension (PAH). Slides are developed and updated throughout the year by leading PAH expert physicians. All content is reviewed and approved by the Simply Speaking PAH Planning Committee.

Outpatient management of PAH requires unique and practical considerations. Further management decisions regarding emerging therapies, chronic anti-coagulation therapy, exercise recommendations, travel considerations, medication adherence, adverse events and psychosocial issues must also be addressed. This slide kit is designed for the multi-disciplinary medical team to address the practical challenges of managing PAH.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Activity Summary:
Talking PAH is a webcast series that highlights the very latest clinical data in pulmonary arterial hypertension. Slides are developed and presented by leading PAH expert physicians and further reviewed and approved by the planning committee.

Through patient cases, Usha Krishnan, MD, DM, FAHA and Nicholas Hill, MD discuss the key considerations to manage patients with pulmonary arterial hypertension (PAH). In Case 1, Dr. Krishnan presents the patient with underlying cardiac defects and repair history and lifelong management in multidisciplinary specialty centers with expertise in pulmonary arterial hypertension - congenital heart disease (PAH-CHD). In Case 2, Dr. Hill discusses how to manage the patient with acute right ventricle (RV) failure.

Activity Summary:

New frontiers for HIV therapy continue to be explored, as underscored by the clinical development and use of new agents, changing regimen strategies and development of long-acting novel agents. This expanding era of simplified and effective HIV therapy presents physicians with many new opportunities and challenges for providing care. To deliver state-of-the-art HIV prevention and care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations in HIV.

This educational Quarterly Brief, covering HIV data from January through March of 2022 will discuss the most clinically relevant information regarding PrEP, HIV cure, treatment experienced patients, long-acting ART and comorbidities.